Liquiritigenin protects against arsenic trioxide-induced liver injury by inhibiting oxidative stress and enhancing mTOR-mediated autophagy
Liquiritigenin (LQ) has protective effects against various hepatotoxicities. However, its specific role on arsenic trioxide (ATO)-induced hepatotoxicity and the related biomolecular mechanisms remain unclear. The purpose of this study is to explore the protective actions of LQ on ATO-induced hepatot...
Main Authors: | Muqing Zhang, Yucong Xue, Bin Zheng, Li Li, Xi Chu, Yang Zhao, Yongchao Wu, Jianping Zhang, Xue Han, Zhonglin Wu, Li Chu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-11-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332221009513 |
Similar Items
-
Stereospecific pharmacokinetic characterization of liquiritigenin in the rat
by: Samaa Alrushaid, et al.
Published: (2017-01-01) -
Pharmacological characterization of liquiritigenin, a chiral flavonoid in licorice
by: Samaa Alrushaid, et al.
Published: (2016-01-01) -
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
by: Zhilin Zou, et al.
Published: (2020-03-01) -
Liquiritigenin reduces osteoclast activity in zebrafish model of glucocorticoid-induced osteoporosis
by: Marta Carnovali, et al.
Published: (2020-08-01) -
mTOR signaling pathway and mTOR inhibitors in the treatment of cancer
by: Mehmet Küçüköner, et al.
Published: (2013-03-01)